Showing results (111-120 of 133) with videos related to
Sort By:
Pageof 14
Dermatology and Therapy|June 26, 2025
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic DermatitisJonathan I Silverberg, Melinda Gooderham, Andreas Wollenberg, et al.Journal of Drugs in Dermatology : JDD|January 6, 2026
Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United StatesKatrina Abuabara, Christopher G Bunick, Lara Wine Lee, et al.Molecular Biology of the Cell|January 17, 2014
Critical roles for multiple formins during cardiac myofibril development and repairMichelle Rosado, Cynthia F Barber, Cristina Berciu, et al.European Journal of Pediatrics|January 22, 2022
Review of the holistic management of pediatric atopic dermatitisArmaan Guraya, Karan Pandher, Caroline L Porter, et al.American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.Journal of Drugs in Dermatology : JDD|February 8, 2022
2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and CareFolawiyo Babalola, Cameron Moattari, Brian Berman, et al.Journal of Cutaneous Medicine and Surgery|September 1, 2018
A Pilot Study Characterizing Factors in Adherence to Cutaneous Lupus TreatmentTeresa Ro, Rechelle Z Tull, Leah A Cardwell, et al.Dermatology and Therapy|May 11, 2024
Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in ChinaYehong Kuang, Yuzhen Li, Chengzhi Lv, et al.Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.JAMA Dermatology|June 11, 2020
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017Melissa R Laughter, Mayra B C Maymone, Chante Karimkhani, et al.Pageof 14